Yukun (Beijing) Technology Co.

Beijing, China  All China companies → Founded 2017
Clinical AI Platform Imaging AI Specialist
Cardiology Radiology Vascular Surgery
Neurology AI Radiology & Imaging AI
Venture Capital-Backed (previously sought IPO) — $309 million (as of September 2021)

Products

CerebralGo Plus
Yukun (Beijing) Technology Co., Ltd.
Neurology AI
CerebralGo Plus is an FDA-cleared medical image management and processing software for adult CT Angiography (CTA) scans, designed for trained professionals to view and process imaging datasets within a hospital network.

See all 1 product →

About Yukun (Beijing) Technology Co.

Yukun (Beijing) Technology Co., Ltd., also known as Shukun Technology, is a prominent healthcare AI company dedicated to advancing smart healthcare through its AI-powered “Digital Doctor” platform. The company’s core mission is to enhance the efficiency, accuracy, consistency, and accessibility of patient care by providing advanced diagnostic and treatment solutions. Shukun specializes in medical imaging AI, with a strong focus on cardiovascular and cerebrovascular diseases, including acute stroke and ischemic heart disease. Their comprehensive “Digital Body AI Platform” encompasses over 40 AI-powered products designed to analyze various imaging modalities such as CT, MRI, X-ray, mammography, and ultrasound, covering major organs like the heart, brain, chest, abdomen, and musculoskeletal system.

For physicians, Shukun’s technology offers critical support throughout the patient journey, from initial screening and diagnosis to treatment planning and surgical guidance. Products like PerfusionGo Plus, a Picture Archiving and Communications System (PACS) for CT perfusion imaging analysis of the brain, and CerebralGo Plus, an image processing software for adult CT angiography (CTA) of the brain, exemplify their offerings. Additionally, their Shukun CTA and Shukun CT-FFR software aid in the diagnosis of coronary artery stenosis and ischemic heart disease by evaluating coronary artery morphology and performing hemodynamic analysis. These deep learning-based algorithms intelligently analyze medical images, automatically identify lesions, and generate reports, aiming to streamline workflows and improve diagnostic precision. As of March 31, 2025, Shukun has secured numerous regulatory approvals globally, including 17 NMPA Class III, 14 NMPA Class II, 10 MDR CE, 1 PMDA, and 2 FDA approvals, with its products integrated into over 3,000 hospitals and 1,000 health check-up centers worldwide. The company is also exploring the integration of Large Language Model (LLM) functions with hardware for future innovations.

Focus Areas

Medical AI AI-assisted diagnostic tools cardiovascular disease screening surgical guidance acute stroke imaging cerebrovascular disease imaging cardio-cerebral imaging medical imaging analysis digital body platform deep learning algorithms large language models in healthcare

Business Intelligence

Key InvestorsSequoia Capital China, Qiming Venture Partners, BOC International Holdings, China Creation Ventures, Morningside Venture Capital
PartnershipsClairvo Technologies (Japan)
AcquisitionsBone's Technology
TechnologyMedical AI neural networks, deep learning algorithms, software-driven, fully automated, Digital Body AI Platform, DICOM-compliant, integrating Large Language Model (LLM) functions
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Medical AI & AI-Assisted Diagnostic Tools
Yukun (Beijing) Technology Co. specializes in leveraging medical AI neural networks to provide intelligent diagnosis and treatment solutions across various diseases. Their tools assist in image viewing, processing, and analysis for clinical decision-making.
Cardiovascular & Cerebrovascular Imaging
The company offers advanced imaging solutions for acute stroke, cerebrovascular diseases, and cardiovascular disease screening. They have achieved breakthrough innovation in cardio-cerebral imaging through differentiated clinical pathways.
Surgical Guidance
Yukun provides services that include AI-assisted surgical guidance, enhancing precision and outcomes for medical procedures.
Medical Imaging Analysis
Their products, such as CerebralGo Plus and PerfusionGo Plus, are software packages designed for comprehensive medical image management and processing. They offer viewing, processing, and analysis capabilities for DICOM-compliant CTA and CT perfusion imaging datasets.
Digital Body Platform & 3D Modeling
Yukun's AI can model a patient's organs based on CT scans, generating detailed 3D representations that enable more accurate examination and diagnosis for physicians.
Deep Learning Algorithms
The foundation of their AI solutions lies in deep learning algorithms, specifically medical AI neural networks, which power their smart diagnosis and treatment systems.
Physician Tip

For physicians, Yukun's solutions offer significant advantages by providing AI-assisted diagnostic tools that deliver smart diagnosis and treatment insights. Their ability to generate detailed 3D representations of organs from CT scans can lead to more accurate examinations and diagnoses. Products like CerebralGo Plus and PerfusionGo Plus enhance clinical decision-making by offering advanced viewing, processing, and analysis of medical images, including critical parameters for tissue flow and blood volume in brain CT perfusion scans. The DICOM compliance and compatibility with standard 'off-the-shelf' hardware and virtual platforms suggest a streamlined integration into existing clinical workflows, minimizing disruption and maximizing utility. It's important to note that while these tools provide valuable information, they are generally not intended for primary diagnostic use but rather to support trained clinicians.

Yukun's software solutions are designed to be highly interoperable within existing healthcare IT infrastructures. They are DICOM-compliant, ensuring seamless integration with various medical imaging devices and Picture Archiving and Communication Systems (PACS). The software runs on standard 'off-the-shelf' hardware and can be deployed on virtual platforms like VMware, offering flexibility and ease of integration into diverse hospital and clinic environments.

Products by Yukun (Beijing) Technology Co.

1 product in the directory

CerebralGo Plus
Yukun (Beijing) Technology Co., Ltd.
Neurology AI
CerebralGo Plus is an FDA-cleared medical image management and processing software for adult CT Angiography (CTA) scans, designed for trained professionals to view and process imaging datasets within a hospital network.

What the Web Says

Yukun (Beijing) Technology Co. appears to be a company focused on medical image processing software, with products like CerebralGo Plus and PerfusionGo Plus, which have received FDA 510(k) clearance. These products are intended for use by trained medical professionals for viewing and processing imaging datasets from DICOM-compliant devices, specifically for adult CTA and CT perfusion scans of the brain, respectively. While there is information about their products' regulatory status and technical specifications, comprehensive public reviews from platforms like G2, Glassdoor, Capterra, or Reddit regarding either their products or their employer practices are not readily available.

Overall: Mixed

Strengths

  • FDA 510(k) cleared products (CerebralGo Plus, PerfusionGo Plus) for medical image processing.
  • Software runs on standard 'off-the-shelf' hardware.
  • Products are DICOM compliant for data and image acquisition.
  • Software performance testing met design requirements.
  • PerfusionGo Plus achieved pre-established performance goals for perfusion parameters.

Limitations

  • Lack of readily available product reviews on major platforms (G2, Capterra).
  • No employer reviews found on Glassdoor or Indeed specifically for Yukun (Beijing) Technology Co.
  • Limited public discussion or reviews on Reddit.
  • Products are not intended for primary diagnostic use.

Based on reviews from: accessdata.fda.gov, PatSnap Discovery

Last updated: 2026-07-20

Videos

News, demos, and interviews about Yukun (Beijing) Technology Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for Yukun (Beijing) Technology Co. →

View all on YouTube

Press & Coverage

U.S. Food and Drug Administration
FDA 510(k) Premarket Notification for CerebralGo Plus
Yukun (Beijing) Technology Co., Ltd. received FDA 510(k) clearance for CerebralGo Plus, an image processing software package designed for viewing and processing adult CT Angiography (CTA) datasets.
2023-04
U.S. Food and Drug Administration
FDA 510(k) Premarket Notification for PerfusionGo Plus
Yukun (Beijing) Technology Co., Ltd. secured FDA 510(k) clearance for PerfusionGo Plus, a medical image processing software used to analyze and communicate brain CT perfusion scans.
2023-01
PubMed / Neuroradiology Journal
Comparison of two computed tomography perfusion post-processing software to assess infarct volume in patients with acute ischemic stroke
A peer-reviewed study evaluated and compared the diagnostic utility and volumetric agreement of Shukun-PerfusionGo (developed by Yukun/Shukun Technology) against Olea Sphere for predicting final infarct volume in stroke patients.
2023-04
Radiology (RSNA)
Deep Learning for Head and Neck CT Angiography: Stenosis and Plaque Classification
This peer-reviewed research utilized automatic image reconstruction systems from Yukun (Beijing) Technology to process head and neck CT angiography images for vessel segmentation and plaque classification.
2023-03
Juntendo University Hospital
Joint Research Agreement on CT-FFR Analysis with Juntendo University and Clairvo Technologies
A clinical research protocol outlines a collaborative study involving Juntendo University, Clairvo Technologies, and Shukun/Yukun (Beijing) Technology Co., Ltd. to evaluate and verify CT-FFR analysis results.
2024-09
Frontiers in Aging Neuroscience / PMC
Cognitive outcomes after extracranial-intracranial bypass surgery in elderly patients diagnosed with atherosclerotic cerebral steno-occlusive artery disease
A clinical study utilized the PerfusionGo V1.0 brain perfusion CT image processing software developed by Shukun (Yukun Technology) to analyze cerebral blood flow and mismatch volumes in elderly surgical patients.
2025-03

Frequently Asked Questions

Yukun (Beijing) Technology Co., also known as Shukun Technology, offers a 'Digital Body Platform' with over 40 AI-powered products covering major organs, including the heart and brain. Key products include Shukun CTA and Shukun CT-FFR for cardiovascular disease screening and diagnosis, and CerebralGo Plus and PerfusionGo Plus for cerebrovascular and acute stroke imaging analysis. These tools leverage deep learning algorithms to provide detailed image processing and analysis, aiding in the evaluation of conditions like coronary artery stenosis and brain perfusion.
Yukun Technology demonstrates strong regulatory compliance, holding 2 FDA approvals, 17 NMPA Class III, 14 NMPA Class II, and 10 MDR CE approvals as of March 2025. Their products, such as CerebralGo Plus and PerfusionGo Plus, have received FDA 510(k) clearances and are DICOM compliant, ensuring interoperability and adherence to medical device standards. The company actively seeks necessary regulatory approvals for market entry, as seen with their partnership to introduce products in Japan.
Yukun Technology extensively utilizes deep learning algorithms, forming the core of its medical AI neural networks for smart diagnosis and treatment solutions. The company is also actively researching and developing capabilities to integrate Large Language Model (LLM) functions with hardware design and deployment. This aims to position their AI as a 'seamless copilot' within global healthcare systems, enhancing efficiency and decision support.
Yukun Technology has established significant partnerships, including a comprehensive strategic alliance with Clairvo Technologies to introduce its medical imaging AI products in the Japanese market. Globally, their products are embedded in the workflows of over 3,000 hospitals and 1,000 health check-up centers. In China, their AI-assisted diagnostic tools are utilized in a substantial number of top-tier hospitals.
Yukun Technology has demonstrated strong financial backing, raising over $309 million since 2017, including significant funding rounds led by investors like Sequoia Capital China. The company applied for a Hong Kong IPO in 2021, reflecting its growth ambitions. While experiencing rapid revenue growth, it also reported increased losses, common for high-growth tech firms investing heavily in R&D and market expansion.
Yukun Technology provides AI-assisted services for surgical guidance, aiming to help doctors plan surgeries faster and more accurately. Their AI-powered diagnostic tools, such as those for cardiovascular disease, use software, databases, and machine learning algorithms to model organs and analyze medical images. This allows for more precise assessment of conditions like coronary stenosis, providing objective insights that can enhance clinical decision-making.
While specific support details like pricing are not publicly available, Yukun Technology's products are designed to run on standard 'off-the-shelf' hardware and are DICOM compliant, facilitating integration into existing hospital workflows. The widespread adoption of their products in thousands of hospitals globally suggests a robust implementation and support infrastructure. Their focus on reducing workload and improving efficiency for radiologists and physicians implies a commitment to user-friendly solutions and necessary assistance.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.